Nasus Pharma Ltd.

NSRX

Healthcare Drug Manufacturers General

2.82 0.09 −3.09%
Market cap
$34.1M
P/E
—
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
0.00%
Net debt / EBITDA
0.3×
Dividend safety
n/a

Nasus Pharma Ltd. (NSRX) P/E ratio

Alert me on P/E ratio

P/E ratio, daily

No history to chart for NSRX yet.

Annual newest first

Period P/E ratio Change

P/E ratio against peers

Company P/E ratio
MIRA MIRA Pharmaceuticals, Inc. compare n/m
MDCX Medicus Pharma Ltd compare n/m
SCLX Scilex Holding Company compare n/m
AMRN Amarin Corporation PLC compare n/m
GSK GSK PLC Sponsored ADR compare 16.7×
OGN Organon & Co. compare 17.3×
GRFS Grifols, S.A. compare 18.2×
BIIB Biogen Inc. compare 105×
NSRX Nasus Pharma Ltd. —
Drug Manufacturers General industry median 26.5×
Healthcare sector median 24.5×
Market median 17.8×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on NSRX